Pharmex, Improving Lives Globally
Through increased access to Innovative Healthcare.
With our purchase, upgrade, and EU recertification of Laboratory Pérez Giménez (LPG) pharmaceutical portfolio (one of Spain’s most successful over the past 70 years) and its production complex (one of the largest in Andalusia, Spain), we are fully equipped to deliver world-class, strategically-impactful CMO and CDMO services to a global clientele.
We currently develop and manufacture a growing list of products that currently include pharmaceuticals, cosmetics, and biocides, while also offering out/in-licensing opportunities in several of these product categories.
Opportunities also exists for co-investment, technical, and marketing partnerships in the development of Value-Added (VA) and other in-demand medicine.
Our Business Services Segment is managed by PHARMEX ADVANCED LABORATORIES, a division of Pharmex Group Spain.
To learn more from our business developers by clicking on the logo:
Pharmex Advanced Laboratories,
Improving lives worldwide through quality nutrition
and greater access to innovative health services.
Pharmex Group Spain is an emerging force in the European CDMO business services space and is well positioned to be a global provider of strategically-impactful, world-class quality healthcare solutions foundationed on its key pillars of in-house/partnership-driven innovation, high precision, and cost-sensitive manufacturing.
With a turnkey value proposition, we provide a wide range of development and manufacturing services aimed at giving our clients/partners a carefree complement to their activities, while adding new ideas and solutions to their portfolio.
Having a multipurpose, EUGMP-certified manufacturing site means we can offer our clients a truly one-stop solution and reliable partnership that allows them to source many of their pharmaceuticals, cosmetics, and biocides requirements in dosage forms consistent with their business objectives.
Contact Pharmex Group at: business@pharmex.es
Pharmex, providing flexible growth solutions across a wide range of product development needs.
Our growing list of manufacturing services currently covers three (3) categories:
Pharmex,
Your value-added partner in the delivery of innovative and cost-effective healthcare solutions.
Pharmex,
Helping you set and attain profitable and impactful beauty trends.
Pharmex,
Bringing hygiene and other healthcare solutions within emerging markets reach.
Services available via Pharmex Group Spain Advanced Laboratories division – (business@pharmex.es)
Pharmex, your value-added partner in the delivery of innovative and cost-effective healthcare solutions.
Explore Our Pharmaceutical Business Services:
Our Pharmaceutical business services value proposition is focused on three (3) complementary services that provide European-class innovative, reliable, and cost-effective solutions to your pharmaceutical development needs:
| MANUFACTURING FACILITIES DIMENSIONS | MULTIPURPOSE CAPABILITIES | FACILITIES CERTIFICATIONS | |||
|---|---|---|---|---|---|
| Total Site Area: 56.642 m2 | Manufacturing Site: 24.550 m2 | Non-Sterile Oral Solids | Semi-Solids | Liquids | REGULATORY CERTIFICATIONS:
|
| Cosmetic (Semi-solids & Liquids) |
|||||
| Possibility to expand current site to accommodate additional capabilities | RESEARCH & CO-DEVELOPMENT ACTIVITIES We offer partners multiple collaborative paths to attain their product development objectives:
| ISO CERTIFICATION: ISO 9001 ISO 14001 ISO 22716 |
|||
Pharmex, helping you set profitable and impactful beauty trends.
Explore Our Cosmetic Business Services:
Equipped with a world-class manufacturing facilities and a young, and innovative beauty care development team, we offer clients:
Pharmex, bringing hygiene and other healthcare solutions within emerging markets reach.
Explore Our Biocides & Other Business Services:
In addition to other planned product categories, our growing range of Biocides services include:
Pharmex SA
20, Rue Du Marché
1204 Geneva, Switzerland
info@pharmex.swiss
T. +41 (0)22 566 14 02
F. +41 (0)22 566 14 03
